Alentar is a company headquartered in the United Kingdom.
Alentar is developing therapies aimed at reversing goblet cell hyperplasia to treat cystic fibrosis and other pulmonary conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.